Enterprise Group PLC (GHSE:EGL)

CTI BioPharma Ratios and Metrics

Market cap in millions GHS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	487	338	408	547	477	239
Market Cap Growth	19.25%	-17.16%	-25.31%	14.70%	99.29%	-15.15%
Enterprise Value	393	299	230	595	464	83
PE Ratio	2.36	1.40	3.51	6.65	7.05	2.94
PS Ratio	0.24	0.17	0.28	0.61	0.41	0.29
PB Ratio	0.29	0.22	0.29	0.42	0.57	0.31
P/FCF Ratio	0.69	0.47	0.93	1.27	1.15	0.98
P/OCF Ratio	0.64	0.45	0.89	1.21	1.11	0.93
EV/Sales Ratio	0.19	0.15	0.16	0.66	0.40	0.10
EV/EBITDA Ratio	1.33	0.85	1.07	-	2.90	0.49
EV/EBIT Ratio	1.46	0.90	1.16	-	3.16	0.52
EV/FCF Ratio	0.56	0.42	0.52	1.39	1.12	0.34
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.05	0.05
Debt / EBITDA Ratio	0.03	0.05	0.06	-	0.24	0.23
Debt / FCF Ratio	0.01	0.03	0.03	0.04	0.10	0.16
Quick Ratio	2.19	6.04	4.30	1.90	1.14	1.14
Current Ratio	2.91	6.72	4.99	2.37	1.18	1.23
Asset Turnover	0.51	0.56	0.53	0.39	0.59	0.51
Return on Equity (ROE)	19.32%	24.62%	14.15%	10.80%	15.37%	20.50%
Return on Assets (ROA)	4.18%	5.97%	4.48%	-0.71%	4.70%	6.14%
Return on Capital (ROIC)	10.03%	13.85%	8.98%	-1.51%	10.94%	13.10%
Earnings Yield	42.36%	71.39%	28.49%	15.04%	14.18%	34.00%
Earnings Yield	42.36%	71.39%	28.49%	15.04%	14.18%	34.00%
FCF Yield	145.05%	211.80%	107.83%	78.53%	86.74%	101.80%
Dividend Yield	4.42%	6.63%	4.49%	2.63%	3.10%	5.32%
Payout Ratio	8.04%	6.86%	10.93%	15.46%	15.67%	11.34%
Buyback Yield / Dilution	0.01%	-	-	-	-	-
Total Shareholder Return	4.43%	6.63%	4.49%	2.63%	3.10%	5.32%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.